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ECGBackground: Even minor ST depression in the electrocardiogram (ECG) is associated with cardiovascular disease
and increased mortality. There is limited data on the prognostic significance of ST-level changes in the general
population.
Subjects and methods: A random sample of Finnish subjects (n = 6354) aged over 30 years (56.1% women)
underwent a health examination including a 12‑lead ECG in the Health 2000 survey. The effects of relative ST
level as a continuous variable and ST slope (upsloping, horizontal, downsloping) in three different lead groups
were analyzed using a multi-adjusted Cox proportional hazard model separately for men and women with
total mortality as endpoint.
Results: The follow-up lasted for 13.7 (SD 3.3) years for men and 13.9 (SD 3.1) years for women. Lower lateral ST
levels were associated with all-cause mortality in multi-adjusted models in both genders (at J + 80 ms hazard
ratio [HR] 0.64 for a change of 1.0 mm [95% confidence interval 0.49–0.84, p = 0.002] for men and HR 0.61
[0.48–0.78, p b 0.001] for women). Associated coronary heart disease had no major influence on the results. Ex-
clusion of subjectswith ECG signs of left ventricular hypertrophy from the analyses increased themortality risk of
lower lateral ST levels inmen but decreased it inwomen. For the anterior and inferior lead groups, no statistically
significant differencewas seen aftermultivariate adjustment. ST slope was not an independent predictor ofmor-
tality after multivariate adjustment.
Conclusion: Lower ST level in the lateral ECG leads is an independent prognostic factor to predict all-cause mor-
tality in the general population.
© 2019 Elsevier Inc. All rights reserved.Introduction
Abnormalities in the electrocardiographic (ECG) ST level reflect ab-
normalities in ventricular repolarization. In earlier population studies,
major ST depression has been associated with worse outcome and risk
for cardiovascular disease [1–3], and also minor ST changes had an ad-
verse effect on prognosis [4–7]. In most of the studies, outcome wasdicine, Vaasa Central Hospital,determined by the magnitude of these ECG changes [4]. Some studies
even suggested that ST depression was associated cardiovascular
death in a “dose-response” manner [8]. However, there are only few
studies examining the ST level as a continuous instead of a categorical
variable.
A downsloping ST segment, especially in exercise testing, is consid-
ered typical for coronary artery disease [9]. Also, a downward sloping
ST segment together with T-wave inversion in the lateral leads, the
“strain pattern”, is a marker of anatomical left ventricular hypertrophy
(LVH) and is associatedwith increased left ventricularmass andmortal-
ity [10]. There is very limited data on the prognostic value of ST slope as
Fig. 1. An ECG example of a 59-year-old male participant who died during the follow-up.
The ST segment in lead aVL is downsloping. Comparedwith the reference line, the level of
the J point is−0.15mm,while the level at themeasurement point J+80ms is−0.75mm.
The lowest J point in the lateral leads is in V5 (−0.40 mm). The ECG was recorded at
50 mm/s and 10 mm/mV.
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the general population.
The prognostic value of ST changes is dependent of the location of
the changes within the 12‑lead ECG [8,11]. Nevertheless, many authors
did not specify the location of ST changes in their analyses. Gender dif-
ferences in cardiovascular diseases have received attention in preven-
tive cardiology. Previously most of the studies dealing with ST changes
includedmoremen thanwomen. Lately, some studies have also focused
on women, and it seems that the prognostic significance of these ECG
changes is similar in both genders, especially when it comes to minor
changes [3,4,12,13].
The aim of this studywas to establish the prognostic role of the level
of the ST segment and of the ST slope, separately in three different ana-
tomical lead groups, in bothmen andwomen in the general population.
Materials and methods
Study population
The study is based on the Health 2000 survey, whichwas carried out
in 2000–2001. The study design has been described more in detail pre-
viously [14]. The population-based nationwide study consisted of 8028
individuals aged over 30 years, of whom 79% (6354 individuals) partic-
ipated in the health examination,which included a structured examina-
tion by a physician, series of laboratory tests and an ECG recording. The
study was designed to cover a nationally representative population
sample of the Finnish population. Individuals aged 80+ were
oversampled using double inclusion probabilities. Ethical approval for
the Health 2000 study was obtained from the Ethical Committee for Re-
search in Epidemiology and Public Health at theHospital District of Hel-
sinki and Uusimaa (HUS).
ECG registration, definitions and analysis
During the health examination, a standard 12‑lead resting ECG in su-
pine position was recorded from each subject with Marquette Hellige
MAC 5000 electrocardiographs (Freiburg, Germany and Milwaukee,
WI, USA). ECGs were stored electronically and printed at a paper
speed of 50 mm/s. The low-pass filter was set at 150 Hz. If the partici-
pant had significant muscular tremors that interfered with the record-
ing, the filter was set at 40 Hz. High-pass filter 0.16 Hz was used. The
Marquette 12SL program can use high-pass filter at 0.32 Hz without in-
ducing artifacts to the ST level measurements. The ECG data were sent
for further analysis to the Social Insurance Institution's research center
in Turku, where ECGs were analyzed with Magellan software (Mar-
quette Electronics Inc., Milwaukee, WI, USA). ST levels and durations
and amplitudes of different waves of every single 12‑lead ECG were
measured. The Marquette 12SL algorithm uses median complexes of
the 10-s ECG tracing and uses the onset of QRS as an isoelectric line.
The Minnesota coding was performed at the Institute of Cardiology,
Kaunas Medical Academy, Lithuania, by two investigators blinded to
the clinical data. The repeatability of the Minnesota Code was checked
by repeat analysis of 200 ECGs.
The following three lead groups were used in the present study: an-
terior (leads V1-V4), lateral (aVL, I, V5-V6) and inferior (II, aVF, III). In
addition, lead V5was included as a single lead. ST levels weremeasured
at the J point and 80 ms after the J point (J + 80 ms). The lead with the
lowest ST level in a particular lead groupwas used for analysis. An addi-
tional parameter “JaltJ + 80 ms”was also created, and it was defined as
the lower ST level of the J point and J + 80 ms measurement points. ST
slope was defined as the difference between the ST level at the
J + 80 ms and J point in a single lead. If the absolute value of difference
between the measurement point at J + 80 ms and the J point was
≤0.5 mm, the ST segment was classified as horizontal. If the measure-
ment point J + 80 ms was N0.5 mm higher than the J point, the ST
slope was labeled as positive (upsloping ST segment). Finally, if themeasurement point J + 80 ms was N0.5 mm lower than the J point,
the ST slope was classified as negative (downsloping ST segment). The
leadwith the lowest singlemeasurement at J point or J + 80mswas se-
lected to represent the lead group. Fig. 1 shows an example of a
downsloping ST segment, and also the measurement points: the J
point and J + 80 ms.
Follow-up
The data for mortality and follow-up until the end of the year 2015
were gathered from the Causes of Death register maintained by Statis-
tics Finland. It contains 100% of deaths of Finnish citizens in Finland
and almost 100% abroad. Databases were linked using a personal iden-
tity code. The endpoint of this study was mortality from any cause and
the follow-up time was the time between entering the study and time
of death or the end of follow up at the end of 2015.
Medication
Information about the prescribed baseline medication was gathered
by checking the study participants' personal health insurance cards for
rights of drug reimbursements and interviewing the study participants
about prescription and non-prescription medicines. The names of the
medications were checked from prescriptions or packages. Also, data
from a separate registry (Statistics on reimbursements for prescription
medicines: The Social Insurance Institution of Finland) was included
in the definition of coronary heart disease (CHD).
Definitions of CHD,myocardial infarction, LVH and chronic obstructive pul-
monary disease
Trained study personnel performed the health interview, and they
followed a structural detailed written instruction to gather information
about pre-existent diseases. Examining physicians performed another
structured interview and physical examination. Information on CHD
was obtained from the Care Register for Health Care maintained by Na-
tional Institute for Health and Welfare, which contains data of all
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registers has been validated previously [15,16].
Classification of CHD required at least one of the following: diag-
nosed angina pectoris, myocardial infarction, percutaneous coronary in-
tervention (PCI) or bypass surgery by examining physician, diagnosed
PCI or bypass surgery in the health interview, ICD-codes 410-414
(ICD8/9) or I20-I25 (ICD10) in the Care Register for Health Care before
the reference date of the study, or the right for drug reimbursements
for CHD. Classification ofmyocardial infarction required either a diagno-
sis of a history of a myocardial infarction by the examining physician,
large Q waves in the resting ECG or a history of myocardial infarction
in the Care Register for Health Care, ICD-codes 410 (ICD8/9) or I21-I22
(ICD10). LVH was defined by Minnesota code criteria 3-1, 3-3 or 3-4
[17]. For the diagnosis of chronic obstructive pulmonary disease
(COPD), information gathered during the health interview was used.
Other measurements and definitions
Height, weight and waist circumference were measured and body
mass index (BMI) was calculated. Blood pressure was measured from
the right arm with a standard mercury manometer (Mercuro 300;
Speidel & Keller, Jungingen, Germany). An average of two measure-
ments was used, of which the first was measured after rest for at least
5 min in sitting position. Hypertension (arterial hypertension, HTA)
was defined as a blood pressure ≥ 140/90 at the baseline.
Serum total cholesterol, high-density lipoprotein cholesterol (HDL),
low-density lipoprotein cholesterol (LDL), triglyceride and plasma glu-
cose concentrations were determined enzymatically from venous
blood samples with a clinical chemistry analyzer (Olympus, AU400,
Hamburg, Germany). The diagnosis of diabetes mellitus (DM) at base-
line was determined as fasting serum glucose (fS-Gluc) ≥ 7 or a history
of use of oral glucose lowering agents or insulin injections [18].
Exclusion criteria
We excluded subjects with missing ECG data (n= 55). Of those, the
recording was unsuccessful in 36 participants with entries such as “dif-
ficult to move,” “wheelchair”, “denial”, “leg/hand amputated”, “in geri-
atric chair”, “massive hernia”, “plaster in leg/hand”. In the further
process, 19 ECGs were lost (diskette lost 9, coupling error 4, data read-
ing failure 5, unspecific reason 1).We also excluded subjects with either
large Q/QS waves in the ECG using Minnesota codes 1-1, 1-2 and 1-3
(n = 127), left or right bundle branch block or left anterior hemiblock
(Minnesota code 7, n = 565), Wolf-Parkinson-White pattern (Minne-
sota code 6-4, n = 1) or paced rhythm (Minnesota code 6-8, n = 4)
from the analysis. Thereby, the final study population consisted of
5613 subjects, of which 2462 were males and 3151 females.
Statistical analysis
All analyseswere done separately formen andwomen. Comparisons
in variables were calculated with either t-test, Mann-Whitney U or Chi-
square tests as appropriate. ST levels were treated as continuous vari-
ables. The normality of the distribution of ST-segment levels was esti-
mated with Q-Q plots and histograms. The linearity of the association
of ST level and mortality was checked in a spline model. After visual in-
spection the association did not significantly differ from linear. Hence,
we did not test the linearity in other ways. Cox proportional hazard
models were constructed separately for minimum ST levels and ST
slopes in every lead group and at all measurement points. Total mortal-
ity was used as the endpoint. Regarding ST slope, the three previously
mentioned categories (upsloping, horizontal, downsloping) were used
and the upsloping ST segment was used as reference. For ST levels, haz-
ard ratios (HR) were scaled for a change of 1.0 mm. The following pa-
rameters were used for multivariate adjusting: age, BMI, HDL, LDL,
HTA, DM and CHD. Another model was also constructed, whereknownCHDwas excluded from themultivariate adjustment. The linear-
ity analyses were done using R and all other analyses were performed
with SPSS 25. Statistical significance was based on p b 0.05.
Results
Table 1 shows the baseline characteristics and medication of the
study population. Compared with survivors, the non-survivors were
older and more often had co-morbidities. There was higher proportion
of subjects with ECG-LVH in the female non-survivor group compared
to the survivor group, while there was no statistically significant differ-
ence in male subjects in a similar comparison. The use of all studied
medication groups was clearly more frequent among non-survivors
than among survivors. Table 2 shows the mean ST levels and the type
of ST slope in the three lead groups and lead V5 separately for women
and men and for survivors and non-survivors. Non-survivors had rela-
tively lower ST levels in both men and women in every lead group,
and women tended to have slightly lower ST levels than men. The var-
iation of the ST levelswas quite low as themaximumstandard deviation
(SD) was 0.54 mm. Non-survivors also had a higher proportion of neg-
ative ST slopes, especially in women. However, negative ST slope was a
quite rare finding with a prevalence of 0.1% to 5.4% in the population in
the different lead groups.
Themean follow-up time was 13.7 years (SD 3.3 years) for men and
13.9 years for women (SD 3.1 years). Of the male subjects, 487 (19.8%)
died during follow-up compared to 555 (17.6%) women.
ST level and outcome
Lower ST levels were associated with worse outcome in every lead
group at all measurement points and in both genders. Adverse outcome
wasmost evident in the lateral lead group at J+ 80mswith aHRof 0.13
(95% confidence interval [CI] 0.11–0.15, p b 0.001) in women and HR
0.21 (CI 0.17–0.25, p b 0.001) in men for a change of 1.0 mm. Fig. 2
shows the linearity of the unadjusted association of lateral ST levels
andmortality at the measurement point JaltJ + 80ms. After adjustment
for age, the increase in risk of lower ST levels was diminished in the in-
ferior leads, and also for the anterior leads in men. Lower ST level in the
lateral leads at all measurement points in both genders retained its sta-
tistical significance for increasedmortality after adjustingwith age. This
was also the case inwomen at themeasurement point J+80ms and for
JaltJ + 80ms in the anterior leads and V5. For all the othermeasurement
points and lead groups, the statistical significance was lost after adjust-
ment for age. After multivariate adjustment, lower ST levels were asso-
ciated with higher mortality rates in the lateral leads in both genders at
allmeasurement points and in V5 at JaltJ+ 80ms inmen. At all the other
measurement points and lead groups, the statistical significance was
lost after multivariate adjustment. The multi-adjusted hazard ratios
are shown in Table 3.
Significance of ECG-LVH and associated CHD
In multi-adjusted analysis, after the exclusion of the subjects with
ECG-LVH, the mortality risk of lower ST levels in the lateral leads in-
creased in men. The same was true for V5 both at the J point and
JaltJ + 80 ms: HR 0.69 (CI 0.51–0.92, p = 0.011) and HR 0.70 (CI
0.52–0.94, p = 0.019), respectively. However, the effect of excluding
ECG-LVH patients was opposite in women, where only the measure-
ment point J + 80 ms retained its statistical significance in the lateral
leads. Fig. 3 shows the HRs in the multi-adjusted model in lateral
leads separately for men and women after exclusion of subjects with
ECG-LVH. On the other hand, excluding subjects with CHD from multi-
variate adjustment had no clear influence on the results: lower lateral
ST levels remained a significant risk factor in both genders (Fig. 3).
There was one exception: in lead V5 in women, ST level at J + 80 ms
proved to be associated with worse outcome (HR 0.81 [CI 0.67–0.98,
Table 1







Mean/Median/N SD/Q1-Q3/(%) Mean/Median/N SD/Q1-Q3/(%) Mean/Median/N SD/Q1-Q3/(%) Mean/Median/N SD/Q1-Q3/(%)
N 1975 (80.2%) 487 (19.8%) 2596 (82.4%) 555 (17.6%)
Age 47.2 10.9 64.4 13.5 b0.001 48.7 12.0 72.6 12.2 b0.001
BMI (kg/m2) 27.1 4.0 27.1 4.5 0.773 26.5 5.0 28.0 5.0 b0.001
Waist circumference
(cm)
97.3 11.1 99.3 12.3 0.002 87.3 13.1 93.2 12.6 b0.001
Heart rate/min 61.7 10.7 65.7 12.9 b0.001 63.6 10.2 66.9 11.8 b0.001
Regular smoking 533 (27.1%) 150 (30.9%) 0.092 472 (18.3%) 59 (10.7%) b0.001
COPD 18 (0.9%) 19 (3.9%) b0.001 19 (0.7%) 18 (3.2%) b0.001
Hypertension 832 (42.2%) 297 (61.0%) b0.001 828 (32.0%) 367 (66.5%) b0.001
Diabetes 103 (5.2%) 69 (14.2%) b0.001 79 (3.0%) 81 (14.6%) b0.001
LVH 419 (21.2%) 95 (19.5%) 0.406 201 (7.7%) 105 (18.9%) b0.001
CHD 76 (3.8%) 95 (19.5%) b0.001 73 (2.8%) 132 (23.8%) b0.001
Myocardial
infarction
21 (1.1%) 36 (7.4%) b0.001 11 (0.4%) 30 (5.4%) b0.001
Total cholesterol
(mmol/L)
6.0 1.1 5.9 1.2 0.056 5.8 1.1 6.2 1.2 b0.001
HDL (mmol/L) 1.2 0.3 1.2 0.4 0.543 1.5 0.4 1.3 0.4 b0.001
LDL (mmol/L) 3.9 1.0 3.7 1.1 0.002 3.6 1.0 3.9 1.1 b0.001
Triglycerides
(mmol/L)
1.5 1.1–2.2 1.4 1.1–2.0 0.478 1.2 0.9–1.6 1.5 1.1–2.0 b0.001
CRP (mg/L) 0.7 0.33–1.6 1.2 0.4–3.1 b0.001 0.7 0.2–1.9 1.1 0.4–3.1 b0.001
Uric acid (μmol/L) 337.5 69.0 348.9 81.7 0.005 258.2 65.7 310.0 86.3 b0.001
Medication
Beta-blocker 158 (8.0%) 116 (23.8%) b0.001 300 (11.6%) 172 (31.0%) b0.001
CCB 71 (3.6%) 54 (11.1%) b0.001 109 (4.2%) 87 (15.7%) b0.001
Digitalis 9 (0.5%) 19 (3.9%) b0.001 8 (0.3%) 43 (7.7%) b0.001
ACEI/ARB 124 (6.3%) 72 (14.8%) b0.001 155 (6.0%) 92 (16.6%) b0.001
BMI=bodymass index, COPD=chronic obstructive pulmonary disease, LVH= left ventricular hypertrophy, CHD=coronary heart disease, HDL=high-density lipoprotein, LDL= low-
density lipoprotein, CCB= calcium channel blocker, ACEI = angiotensin-converting enzyme inhibitor, ARB= angiotensin II receptor antagonist, SD= standard deviation, N = number,
Q1-Q3 = quartiles.
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ECG-LVH subjects or adjustment for associated CHD did not influence
the prognostic significance of ST levels (data not shown).
ST slope
A downsloping ST segment in the lateral leads was associated with
higher mortality rates in both genders. This was most evident in lead
V5 in women; 19 out of 22 female study participants with a
downsloping ST segment died during the follow-up (HR 15.09 [CI
9.11–24.99, p b 0.001]). The corresponding HR for men was 3.69 (CI
1.37–9.92, p = 0.010). In women, a negative ST slope was also associ-
ated with increased mortality in the anterior leads, while a horizontal
ST, compared with upsloping ST, was associated with better outcome
when present in the inferior leads (HR 0.44 [CI 0.32–0.62, p b 0.001])Table 2
Mean ST (the lowest of J and J + 80 ms (JaltJ + 80 ms)) levels and standard deviation (SD) an
Variable
Men
Survivors (N = 1975) Non-surviv
ST segment, mean (mm) (SD)
Anterior 0.01 (0.54) −0.1
Lateral −0.04 (0.26) −0.2
Inferior −0.11 (0.34) −0.1
V5 0.20 (0.38) −0.0





N = number, SD = standard deviation.and worse outcome when present in V5 (HR 1.51 [CI 1.19–1.92, p =
0.001]). Also, in men, a horizontal slope in V5 was associated with
worse outcome (HR 2.11 [CI 1.76–2.52, p b 0.001]). However, after
adjusting for age, a downsloping ST segment did not affect outcome in
men in any lead groups. In women, a downsloping or horizontal slope
was associated with worse outcome in the lateral leads as did also a de-
scending slope in V5. Aftermultivariate adjustment, ST slope lost its sta-
tistical significance to predict mortality in all lead groups in both
genders (data not shown). Excluding subjects with ECG-LVH did not
have any significant effect on the multivariate adjusted results. How-
ever, a downsloping ST segment in the lateral leads proved to be a risk
marker for all-cause mortality in women, when CHD was excluded
from the multivariate adjustment model (HR 1.70 [CI 1.04–2.78, p =
0.036] compared to HR 1.62 [CI 0.99–2.66, p = 0.056] in multivariate
adjusted model with CHD).d the percentages of different ST slope groups.
Women
ors (N = 487) p value Survivors (N = 2596) Non-survivors (N = 555) p value
0 (0.43) b0.001 −0.13 (0.27) −0.29 (0.40) b0.001
0 (0.32) b0.001 −0.20 (0.32) −0.32 (0.38) b0.001
6 (0.28) b0.001 −0.09 (0.24) −0.16 (0.32) b0.001
5 (0.42) b0.001 0.01 (0.27) −0.22 (0.43) b0.001
40.6/0.2 0.846 44.1/55.8/0.1 46.7/52.6/0.7 0.003
78.4/1.6 0.026 8.9/90.4/0.7 6.8/87.7/5.4 b0.001
2.0/1.8 0.080 3.0/96.0/1.0 7.0/91.0/2.0 b0.001
55.9/0.8 b0.001 20.7/79.2/0.1 13.9/82.7/3.4 b0.001
































Fig. 2. The unadjusted hazard ratios between ST segment and mortality at measurement
point JaltJ + 80 ms (lower of J point and J + 80 ms) in lateral leads in men and in
women among normal ranges of ST-level measurements. The risk for mortality
increases along the lower ST levels.
Table 3
Mortality of continuous ST levels in different lead groups inmen andwomen,multivariate
adjusteda Cox regression analysis. Hazard ratios are scaled for a change of 1.0 mm.
Men Women
Hazard ratio (95% CI) p value Hazard ratio (95% CI) p value
Anterior
J point 1.06 (0.85–1.30) 0.621 0.93 (0.72–1.20) 0.557
J + 80 ms 1.11 (0.90–1.36) 0.318 0.85 (0.68–1.05) 0.134
JaltJ + 80 ms 1.05 (0.85–1.30) 0.641 0.90 (0.70–1.15) 0.411
Lateral
J point 0.70 (0.54–0.91) 0.008 0.70 (0.53–0.91) 0.009
J + 80 ms 0.64 (0.49–0.84) 0.002 0.61 (0.48–0.78) b0.001
JaltJ + 80 ms 0.69 (0.53–0.89) 0.005 0.68 (0.54–0.87) 0.002
Inferior
J point 1.12 (0.85–1.48) 0.433 0.96 (0.72–1.29) 0.781
J + 80 ms 1.09 (0.78–1.52) 0.611 0.93 (0.68–1.26) 0.625
JaltJ + 80 ms 1.16 (0.86–1.57) 0.323 0.93 (0.69–1.26) 0.639
V5
J point 0.80 (0.63–1.01) 0.057 0.85 (0.67–1.08) 0.190
J + 80 ms 0.85 (0.71–1.03) 0.094 0.84 (0.69–1.03) 0.086
JaltJ + 80 ms 0.79 (0.63–1.00) 0.046 0.83 (0.67–1.05) 0.116
CI= confidence interval, J+ 80ms= J point+80ms, JaltJ + 80ms= lower of J point and
J + 80 ms.
a Age, body mass index, high-density lipoprotein, low-density lipoprotein, hyperten-
sion, diabetes, coronary heart disease.
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Our population study, with a follow-up of nearly 14 years, showed
that lower ST level in the lateral ECG leads (I, aVL, V5, V6) as a continu-
ous variable is independently associated with all-cause mortality in
both women and men. ST changes in the lateral leads had clearly nega-
tive prognostic impact, while anterior or inferior ST level had no prog-
nostic significance after multivariate adjustment. Some previous
studies have also reported consistency of prognosis between the gen-
ders especially regardingminor, non-specific or “borderline” ST changes
in the general population [3,4,12,13]. We found that age has strong im-
pact on the ST level, as was also documented previously [4,5].
All analyses were done separately for men and women because of
the previously described gender differences related to the relative ST
segment and the T wave in the 12‑lead ECG [11]. We also wanted to
study gender-specific differences in different lead groups and measure-
ment points. In previous studies, the prevalence of minor ST changes
has been greater in women than in men [4]. Also in our study, womenhad lower mean ST levels than men. In the anterior leads, age seemed
to explain the association between lower ST levels and mortality in
men, but in women, lower anterior ST levels increased the risk for mor-
tality also after adjusting with age. However, the HRs did not differ sig-
nificantly between sexes after multivariate adjustment.
ECG-LVH produced strikingly different prognostic implications be-
tween the genders. In women after excluding subjects with ECG-LVH,
only the J + 80msmeasurement point retained its power as a negative
prognosticmarker for all-cause death aftermultivariate adjustment. For
the male subjects, excluding those with ECG-LVH tended to strengthen
the effect of lower lateral ST levels on mortality. Previously, when we
studied continuous ST depression and cardiovascular mortality in the
same population with shorter follow-up, we found a similar effect of
the exclusion of ECG-LVH patients in individuals older than 55 years
[11]. The results of our study indicate that the prognostic significance
of a lower lateral ST level at the J point in women is, at least to some ex-
tent, explained by ECG-LVH. In men, including ECG-LVH into the analy-
ses had an opposite effect, indicating that the adverse prognostic effect
of this ECG change is not related to ECG-LVH.Wehave nodefinite expla-
nation for this gender difference. In our population, there was a higher
proportion of subjects with ECG-LVH in the female non-survivor
group compared to the survivor group, while there was no statistically
significant difference in men (Table 1). Also, more male than female
study participants were excluded from the statistical analyses when
studying the effect of ECG-LVH. Considering the large number of study
participants, we think that this difference did not have major impact
on the results, although this possibility cannot be excluded with cer-
tainty. In an earlier population study of Larsen et al. [1], the prevalence
of voltage-only ECG-LVH increasedwith age inwomen but decreased in
men, which could be one possible explanation for the observed gender
difference.
Many previous studies have evaluated the significance of ST depres-
sion after excluding subjects with known CHD. Interestingly, adjusting
for CHD did not have any major influence on our results. The definition
of CHD in our study included many alternative (even though relevant)
criteria, and the vast majority of subjects with a CHD diagnosis is likely
to be covered. Participants with asymptomatic, and thus undiagnosed
CHD, could dilute the results. However, it should be kept in mind that
the ST level is not normally affected by stable CHD. In a study by
Walsh et al., minor ST-segment and T-wave abnormalities were not as-
sociated with the presence of coronary artery calcium in participants
free of clinical CHD at baseline [19]. Our study results indicate that
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Fig. 3.Hazard ratios of lower lateral ST levels and mortality in different measurement points after multivariate adjustment with† andwithout* coronary heart disease and after excluding
participants with left ventricular hypertrophy. Hazard ratios are scaled for a change of 1.0 mm. CHD = coronary heart disease, LVH = left ventricular hypertrophy, J + 80 ms = J
point + 80 ms, JaltJ + 80 ms = lower of J point and J + 80 ms. †Age, body mass index, high-density lipoprotein, low-density lipoprotein, hypertension, diabetes, coronary heart
disease. *Age, body mass index, high-density lipoprotein, low-density lipoprotein, hypertension, diabetes.
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nostic role on changes in the ST level in the lateral ECG leads. In some
studies,minor ST segment changes associatedwith cardiovascularmor-
tality, but not with non-fatal myocardial infarction, indicating that ar-
rhythmias could be one of the causes of the association [20].
Sympathetic activity is known to cause ST depression in healthy sub-
jects, and it is a known risk factor for cardiac death and arrhythmias
[21,22]. The use of digoxin, which clearly may affect the ST level and
ST slope, was quite rare in this study. In structural heart disease, ECG-
LVHoften accompanies ST depression. In the present study, thenegative
prognostic impact of low lateral ST level remained after the exclusion of
ECG-LVH in men and also in women at J + 80 ms. Structural heart dis-
ease often results in ventricular conduction defects with broad QRS, but
this was an exclusion criterion in this study.
The prognostic role of the ST slope
The early repolarization pattern with a horizontal ST segment has
been associated with cardiovascular and all-cause mortality, while an
elevated J point with upsloping ST segment has not been associated
with adverse prognosis in population studies [23,24]. The “strainpattern”, ST depression with downsloping ST and T-wave inversion, is
a well-recognized marker of anatomical LVH and is associated with
larger left ventricular mass and worse outcome in HTA [25,26], and
was associated with all-cause mortality, systolic dysfunction, and myo-
cardial scar inmultiethnic participants of a population study [10]. To our
knowledge, the role of the ST-segment morphology independently of
the level of the ST segment has not been established before.
We found that a downsloping ST segment was associated with in-
creased all-causemortality in the lateral leads (and V5) in both genders
and in the anterior leads in women regardless of the level of the ST seg-
ment. Interestingly, in our study, a horizontal ST segment in the inferior
leads was even associated with a better prognosis than an upsloping ST
in women. In V5, the associated mortality increased among the groups
in both genders: a horizontal ST segment was associated with higher
mortality rates compared to an upsloping ST segment, and a
downsloping ST segment was associated with even higher mortality
rates. After multivariate adjustment, a downsloping ST segment lost
its significance in all lead groups in both genders, but in the multi-
adjusted model without CHD, lateral negative slope increasedmortality
in women. We hypothesize that CHD should be suspected in case of a
downsloping ST segment in the lateral leads in women.
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Most of the previous population studies classified ST changes based
on the Minnesota coding, ignoring the location of ST and T-wave
changes within the 12‑lead ECG. A few studies showed that the progno-
sis of ST changes vary depending on their location over different lead
groups [8,11]. We divided the leads into three anatomical groups, and
these carried clearly different prognostic values. Age seemed to explain
the adverse prognosis of lower ST levels in the inferior and anterior
leads, while lower lateral ST level remained as an independent risk fac-
tor for increased mortality also after multivariate adjustment.
The chosenmeasurement point for ST deviations vary between stud-
ies. Our earlier account from the same data with shorter follow-up [11]
used three different measurement points. Neither shorter nor the cur-
rent longer follow-up differentiated HRs between different measure-
ment points. However, the increase in the risk was somewhat more
pronounced when using the measurement point J + 80 both in multi-
adjusted models and after excluding ECG-LVH.
The variation of the ST level was small, and we used computerized
measurements to measure the level of the ST segment. Automatic mea-
surements help to correct for disturbances caused by wandering base-
line and improve comparison between different ECGs. In our study
HRs were scaled for difference of 1 mm. However, our data suggest
that smaller changes have prognostic effect. Computerized measure-
ment of the ST level is necessary to perform reliable measurements in
case of minor changes.Study limitations and strengths
TheHealth 2000 population is a representative sample of the Finnish
population 30 years of age or older. The results may not be applicable to
other populations. The long follow-up time up to 15 years resulted in a
relatively high mortality rate (19.8% in men and 17.6% in women) for a
population study. As our study contained a relatively high number of
statistical comparisons, borderline significances should be evaluated
with caution. Absence of echocardiographic and magnetic resonance
imaging data on LVH is a study limitation typical of a population study.
Continuous instead of categorical variable enhances sensitivity to
detect subtle differences. Inclusion of lead groups for ST analyses is im-
portant, because the prognostic information clearly differs between the
different categories. The lead with the lowest ST level was chosen to
represent a lead group. This makes our results easy to implement into
clinical practice.
We examined ST slope independently of the level of ST segment. It is
possible that the combination of slope with ST depression would have
altered the study results. This was not the aim of our study, because
the prognostic significance of the lateral “strain pattern” has already
been established in the general population, in hypertension and struc-
tural heart disease.Conclusion
Lower levels of the ST segment in the lateral lead group as a contin-
uous variable is associated with increasedmortality in the general pop-
ulation independently of gender, other cardiovascular risk factors and
CHD. The prognosis is highly dependent on the lead-related spatial re-
gion: in the anterior and inferior lead groups, the ST level did not affect
prognosis after multivariate adjustment. In women, the prognostic ef-
fect of a lower lateral ST level,measured at the J point, is likely explained
by ECG-LVH. Regarding the measurement point J + 80 ms and in male
individuals, more studies are required to understand the pathophysiol-
ogy of the phenomenon. A downward slope of the ST segment in the lat-
eral leadswas associatedwith all-causemortality, but the increased risk
seemed to be explained by age and associated CHD.CRediT authorship contribution statement
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